Faron Pharmaceuticals - Innovative medical solutions (Part 2)

Not all wisdom is concentrated in Turku. Some of it has trickled down to the church in Helsinki as well.
It’s not directly related to Faron.
Complex I drives glutamine-dependent TCA cycle to support viability of MYChigh breast cancer cells
https://www.sciencedirect.com/science/article/pii/S2211124726007072

Tekniikka & Talous covers the same topic in their article:
“This could be the key to defeating cancer – A significant discovery by Finnish researchers
‘Researchers have found a way to influence the energy production of aggressive breast cancer cells. The results are promising.’”
Tämä voi olla avain syövän kukistamiseen – Suomalaisilta tutkijoilta merkittävä löytö | Tekniikka&Talous.

However, this also emphasizes that the era of individual “miracle drugs” in cancer treatment is largely over. The future – and the present – belongs to precisely planned combination therapies, which dismantle cancer’s defense mechanisms from multiple angles at once.

Have a bright weekend!

12 Likes